63 / 44
      65 / 44
      60 / 50

      Wisconsin receives $200,000 in drug settlement

      File photo. (WLUK)
      File photo. (WLUK)
      MADISON (AP) - Wisconsin will receive $200,000 for its Medicaid program from the settlement of a multi-state lawsuit accusing a pharmaceutical company of improperly marketing a drug.Wisconsin State Journal reported Wednesday that Illinois-based Astellas Pharma US Inc. will pay a total of $7.3 million in the settlement with multiple states and the federal government.The Wisconsin Attorney General's Office says in a statement that the company promoted pediatric use of the drug Mycamine from 2005 to 2010, even though the Food and Drug Administration hadn't approved it for children.The anti-fungal agent is approved for use in adults with certain infections. It also can be used to prevent infections in adults undergoing stem cell transplants.